Compare Procter & Gamble Health with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ORCHID PHARMA LTD - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ORCHID PHARMA LTD PROCTER & GAMBLE HEALTH/
ORCHID PHARMA LTD
 
P/E (TTM) x 53.2 -0.5 - View Chart
P/BV x 4.6 0.1 3,926.9% View Chart
Dividend Yield % 10.3 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ORCHID PHARMA LTD
Sep-13
PROCTER & GAMBLE HEALTH/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs3,549194 1,829.4%   
Low Rs1,30135 3,718.0%   
Sales per share (Unadj.) Rs511.4276.5 185.0%  
Earnings per share (Unadj.) Rs61.3-79.2 -77.4%  
Cash flow per share (Unadj.) Rs74.0-43.5 -170.3%  
Dividends per share (Unadj.) Rs440.000-  
Dividend yield (eoy) %18.10-  
Book value per share (Unadj.) Rs927.853.9 1,720.1%  
Shares outstanding (eoy) m16.6070.45 23.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.70.4 1,144.9%   
Avg P/E ratio x39.6-1.4 -2,737.3%  
P/CF ratio (eoy) x32.8-2.6 -1,243.4%  
Price / Book Value ratio x2.62.1 123.1%  
Dividend payout %717.90-   
Avg Mkt Cap Rs m40,2578,067 499.1%   
No. of employees `0001.12.8 40.5%   
Total wages/salary Rs m1,3132,527 51.9%   
Avg. sales/employee Rs Th7,486.76,956.1 107.6%   
Avg. wages/employee Rs Th1,157.6902.5 128.3%   
Avg. net profit/employee Rs Th897.2-1,993.0 -45.0%   
INCOME DATA
Net Sales Rs m8,49019,477 43.6%  
Other income Rs m244407 59.9%   
Total revenues Rs m8,73419,884 43.9%   
Gross profit Rs m1,4821,103 134.4%  
Depreciation Rs m2112,519 8.4%   
Interest Rs m05,227 0.0%   
Profit before tax Rs m1,514-6,236 -24.3%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66511 12.8%   
Tax Rs m563-125 -449.3%   
Profit after tax Rs m1,017-5,580 -18.2%  
Gross profit margin %17.55.7 308.3%  
Effective tax rate %37.12.0 1,850.2%   
Net profit margin %12.0-28.7 -41.8%  
BALANCE SHEET DATA
Current assets Rs m15,34311,014 139.3%   
Current liabilities Rs m1,96032,060 6.1%   
Net working cap to sales %157.6-108.1 -145.9%  
Current ratio x7.80.3 2,278.4%  
Inventory Days Days4995 51.4%  
Debtors Days Days2834 84.8%  
Net fixed assets Rs m1,20929,440 4.1%   
Share capital Rs m166705 23.6%   
"Free" reserves Rs m15,2352,043 745.9%   
Net worth Rs m15,4013,800 405.3%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m17,59546,510 37.8%  
Interest coverage xNM-0.2-  
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.50.4 115.2%   
Return on assets %5.8-0.8 -760.8%  
Return on equity %6.6-146.9 -4.5%  
Return on capital %10.3-3.7 -274.7%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m1,6367,513 21.8%   
Fx outflow Rs m4,3685,649 77.3%   
Net fx Rs m-2,7321,865 -146.5%   
CASH FLOW
From Operations Rs m-1,3041,682 -77.5%  
From Investments Rs m12,697-9,860 -128.8%  
From Financial Activity Rs m-3016,644 -4.5%  
Net Cashflow Rs m11,093-1,535 -722.7%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 4.6 395.7%  
FIIs % 1.0 3.3 30.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 29.1 55.3 52.6%  
Shareholders   28,591 84,811 33.7%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   UNICHEM LAB  VENUS REMEDIES  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Nov 15, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS